- Home
- SWVL vs TELO Comparison
SWVL vs TELO Comparison
Compare SWVL & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- TELO
- Stock Information
- Founded
- SWVL 2017
- TELO 2021
- Country
- SWVL United Arab Emirates
- TELO United States
- Employees
- SWVL N/A
- TELO N/A
- Industry
- SWVL Business Services
- TELO
- Sector
- SWVL Consumer Discretionary
- TELO
- Exchange
- SWVL Nasdaq
- TELO NYSE
- Market Cap
- SWVL 44.5M
- TELO 52.4M
- IPO Year
- SWVL N/A
- TELO 2024
- Fundamental
- Price
- SWVL $4.75
- TELO $1.16
- Analyst Decision
- SWVL
- TELO
- Analyst Count
- SWVL 0
- TELO 0
- Target Price
- SWVL N/A
- TELO N/A
- AVG Volume (30 Days)
- SWVL 22.5K
- TELO 393.1K
- Earning Date
- SWVL 07-22-2025
- TELO 08-12-2025
- Dividend Yield
- SWVL N/A
- TELO N/A
- EPS Growth
- SWVL N/A
- TELO N/A
- EPS
- SWVL N/A
- TELO N/A
- Revenue
- SWVL $17,207,362.00
- TELO N/A
- Revenue This Year
- SWVL N/A
- TELO N/A
- Revenue Next Year
- SWVL N/A
- TELO N/A
- P/E Ratio
- SWVL N/A
- TELO N/A
- Revenue Growth
- SWVL N/A
- TELO N/A
- 52 Week Low
- SWVL $2.40
- TELO $1.12
- 52 Week High
- SWVL $8.05
- TELO $8.40
- Technical
- Relative Strength Index (RSI)
- SWVL 63.96
- TELO 24.00
- Support Level
- SWVL $3.87
- TELO $1.13
- Resistance Level
- SWVL $4.67
- TELO $1.22
- Average True Range (ATR)
- SWVL 0.49
- TELO 0.12
- MACD
- SWVL 0.04
- TELO -0.01
- Stochastic Oscillator
- SWVL 95.45
- TELO 5.80
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.